Irès van der Zwaan is currently doing her PhD at Uppsala University, Sweden. She received her MSc in Bio-Pharmaceutical Sciences from Leiden University and started her PhD in March 2018. Her research focusses on characterisation of in vitro dissolution methods for assessment of novel pulmonary drug delivery, with a focus on controlled release formulations. The research presented is a collaboration within Swedeliver, between Uppsala University and Nanologica AB.
